{"transactions":[{"id":2326581,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:21:50.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest subject to the Issuer's achievement of pre-defined product development, regulatory and financial goals in 2022. 100% of the options will vest on December 31, 2023, if such pre-defined goals have been achieved in 2022, subject to continuous service through the vesting date."}],"balance_after":87500,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001493152-22-007198","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315222007198/ownership.xml","form_type":"4"}},{"id":2326580,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:21:50.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":87500,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001493152-22-007198","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315222007198/ownership.xml","form_type":"4"}},{"id":2332860,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, no par value","published_at":"2022-03-15T16:19:52.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":25000,"price":1.166,"value":29150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $1.166 per share represents a weighted average of prices ranging from $1.155 to $1.180 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":87080,"source":{"system":"sec-edgar","filing":"0001493152-22-006879","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315222006879/ownership.xml","form_type":"4"}},{"id":2734307,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-30T19:09:10.000Z","date":"2021-04-28","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on April 28, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on April 28, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-21-010271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315221010271/ownership.xml","form_type":"4"}},{"id":2734306,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2021-04-30T19:09:10.000Z","date":"2021-04-28","kind":"tax_withholding","acquired":false,"shares":4620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,000 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":62080,"source":{"system":"sec-edgar","filing":"0001493152-21-010271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315221010271/ownership.xml","form_type":"4"}},{"id":2734305,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2021-04-30T19:09:10.000Z","date":"2021-04-28","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66700,"source":{"system":"sec-edgar","filing":"0001493152-21-010271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315221010271/ownership.xml","form_type":"4"}},{"id":2825586,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-01T16:32:06.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":255000,"price":5.34,"value":1361700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting: Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date."}],"balance_after":255000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0001493152-21-005103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315221005103/ownership.xml","form_type":"4"}},{"id":2939538,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-12-17T17:02:50.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":10000,"price":2.006,"value":20060.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 12, 2019, which erroneously did not combine the shares of common stock acquired by the Reporting Person on September 12, 2019 with the Reporting Person's common stock reported on his Form 4 on July 31, 2018."}],"balance_after":13495,"source":{"system":"sec-edgar","filing":"0001493152-20-023851","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220023851/ownership.xml","form_type":"4/A","original_submission_date":"2019-09-12"}},{"id":2944095,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-12-15T06:13:48.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":10121,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":46700,"source":{"system":"sec-edgar","filing":"0001493152-20-023583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220023583/ownership.xml","form_type":"4"}},{"id":2944093,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-12-15T06:02:37.000Z","date":"2020-09-12","kind":"purchase","acquired":true,"shares":10000,"price":2.006,"value":20060.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 12, 2019, which erroneously did not combine the shares of common stock acquired by the Reporting Person on September 12, 2019 with the Reporting Person's common stock reported on his Form 4 on July 31, 2018."}],"balance_after":13495,"source":{"system":"sec-edgar","filing":"0001493152-20-023578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220023578/ownership.xml","form_type":"4/A","original_submission_date":"2019-09-12"}},{"id":3069182,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, no par value","published_at":"2020-08-04T18:47:18.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":10000,"price":1.32,"value":13200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"2,500.000 shares purchased at $1.3165; 2,500.000 shares purchased at $1.3058; 2,500.000 shares purchased at $1.3169; and 2,500.000 shares purchased at $1.3425."}],"balance_after":36579,"source":{"system":"sec-edgar","filing":"0001493152-20-014611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220014611/ownership.xml","form_type":"4"}},{"id":3166305,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-30T20:08:35.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-007488","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220007488/ownership.xml","form_type":"4/A","original_submission_date":"2020-04-30"}},{"id":3166304,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-30T17:53:19.000Z","date":"2020-04-28","kind":"grant","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-007476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220007476/ownership.xml","form_type":"4"}},{"id":3172945,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-20T16:42:04.000Z","date":"2020-03-14","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on March 14, 2020"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on March 14, 2020"}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-006754","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220006754/ownership.xml","form_type":"4"}},{"id":3172944,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2020-04-20T16:42:04.000Z","date":"2020-03-14","kind":"tax_withholding","acquired":false,"shares":6916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,000 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":26579,"source":{"system":"sec-edgar","filing":"0001493152-20-006754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220006754/ownership.xml","form_type":"4"}},{"id":3172943,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2020-04-20T16:42:04.000Z","date":"2020-03-14","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33495,"source":{"system":"sec-edgar","filing":"0001493152-20-006754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220006754/ownership.xml","form_type":"4"}},{"id":3276403,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase common stock","published_at":"2020-02-12T21:54:48.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on February 10, 2020 and the\nbalance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the\napplicable vesting date."}],"balance_after":204000,"derivative":{"exercise_price":2.63,"expiration_date":"2030-02-09","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001493152-20-002156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315220002156/ownership.xml","form_type":"4"}},{"id":3416015,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, no par value","published_at":"2019-09-12T18:33:12.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":10000,"price":2.006,"value":20060.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-049377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919119049377/doc4.xml","form_type":"4"}},{"id":3590114,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-18T20:02:43.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Grant of restricted stock units under the OncoCye 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-020138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919119020138/doc4.xml","form_type":"4"}},{"id":3590113,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-03-18T20:02:43.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":245000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on March 14, 2019 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date."}],"balance_after":245000,"derivative":{"exercise_price":3.52,"expiration_date":"2019-03-13","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001209191-19-020138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919119020138/doc4.xml","form_type":"4"}},{"id":3857655,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock purchase warrants","published_at":"2018-07-31T21:39:37.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":3495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":3495,"derivative":{"exercise_price":3,"exercise_date":"2019-02-01","expiration_date":"2024-02-01","underlying":"Common stock","underlying_shares":3495},"source":{"system":"sec-edgar","filing":"0001493152-18-010764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315218010764/ownership.xml","form_type":"4"}},{"id":3857654,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock, no par value","published_at":"2018-07-31T21:39:37.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":3495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":3495,"source":{"system":"sec-edgar","filing":"0001493152-18-010764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000149315218010764/ownership.xml","form_type":"4"}},{"id":3892154,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-06-15T18:00:41.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half of the options shall vest upon acceptance of the completion of the clinical validation study manuscript for OncoCyte's DetermaVu product candidate, and the balance shall vest upon the start of the clinical utility study for OncoCyte's DetermaVu product candidate."}],"balance_after":45000,"derivative":{"exercise_price":2.55,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-038141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919118038141/doc4.xml","form_type":"4"}},{"id":3910361,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-06-01T21:26:29.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest as to one-third of the shares on each of the completion of the clinical utility study for OncoCyte's DetermaVu product candidate, the filing of the Medicare dossier for the Medicare local coverage determination, and obtaining a Medicare local coverage determination for OncoCyte's DetermaVu product candidate."}],"balance_after":125000,"derivative":{"exercise_price":2.35,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-18-034891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919118034891/doc4.xml","form_type":"4"}},{"id":3910360,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-06-01T21:26:29.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on the one-year anniversary of the grant date and the balance shall vest thereafter in 36 equal monthly installments."}],"balance_after":50000,"derivative":{"exercise_price":2.35,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-034891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919118034891/doc4.xml","form_type":"4"}},{"id":4157719,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":128993,"kind":"person","name":"Levine Mitchell S","position":1,"cik":"0001383492","reported_name":"Levine Mitchell S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-11-17T20:01:59.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on November 14, 2018, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant."}],"balance_after":200000,"derivative":{"exercise_price":5.9,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-17-061662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383492/000120919117061662/doc4.xml","form_type":"4"}}]}